{"id":"https://openalex.org/W2558136168","doi":"https://doi.org/10.1182/blood.v126.23.2818.2818","title":"Pegylated Interferon Alpha-2a in 75 Patients with Myeloproliferative Neoplasms: A Single Center Experience","display_name":"Pegylated Interferon Alpha-2a in 75 Patients with Myeloproliferative Neoplasms: A Single Center Experience","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2558136168","doi":"https://doi.org/10.1182/blood.v126.23.2818.2818","mag":"2558136168"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.2818.2818","doi":"https://doi.org/10.1182/blood.v126.23.2818.2818","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2818.2818","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050797998","display_name":"Krisstina L. Gowin","orcid":"https://orcid.org/0000-0002-5670-6630","observed_orcids":["https://orcid.org/0000-0002-5670-6630"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Krisstina L. Gowin","raw_affiliation_strings":["Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051833337","display_name":"Tania Jain","orcid":"https://orcid.org/0000-0001-6854-773X","observed_orcids":["https://orcid.org/0000-0001-6854-773X"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tania Jain","raw_affiliation_strings":["Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038693643","display_name":"Heidi Kosiorek","orcid":"https://orcid.org/0000-0002-4651-9516","observed_orcids":["https://orcid.org/0000-0002-4651-9516"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Heidi E. Kosiorek","raw_affiliation_strings":["Mayo Clinic, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Scottsdale, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055454241","display_name":"John Kelly Camoriano","orcid":"https://orcid.org/0000-0002-2957-5356","observed_orcids":["https://orcid.org/0000-0002-2957-5356"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Camoriano","raw_affiliation_strings":["Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018041025","display_name":"Raoul Tibes","orcid":"https://orcid.org/0000-0002-1372-8733","observed_orcids":["https://orcid.org/0000-0002-1372-8733"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raoul Tibes","raw_affiliation_strings":["Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057941081","display_name":"Jeanne M. Palmer","orcid":"https://orcid.org/0000-0002-2185-1504","observed_orcids":["https://orcid.org/0000-0002-2185-1504"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeanne Palmer","raw_affiliation_strings":["Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben A. Mesa","raw_affiliation_strings":["Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ","institution_ids":["https://openalex.org/I4210125099"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5038693643","https://openalex.org/A5057941081"],"corresponding_institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.1747,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.57003517,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"126","issue":"23","first_page":"2818","last_page":"2818"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegylated-interferon-alpha-2a","display_name":"pegylated interferon alpha-2a","score":0.9629999995231628},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":1.0},{"id":"https://openalex.org/keywords/essential-thrombocythemia","display_name":"essential thrombocythemia","score":0.9380000233650208},{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":1.0},{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.984000027179718},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6510000228881836},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.47999998927116394},{"id":"https://openalex.org/keywords/cytoreductive-therapy","display_name":"cytoreductive therapy","score":0.6520000100135803},{"id":"https://openalex.org/keywords/dipss-risk-stratification","display_name":"DIPSS risk stratification","score":0.7080000042915344},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8329490423202515},{"id":"https://openalex.org/C2781057849","wikidata":"https://www.wikidata.org/wiki/Q1368780","display_name":"Essential thrombocythemia","level":3,"score":0.7488361597061157},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7099320292472839},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.6590694189071655},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.6163036823272705},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6142166256904602},{"id":"https://openalex.org/C2780073493","wikidata":"https://www.wikidata.org/wiki/Q7523837","display_name":"Single Center","level":2,"score":0.4315229058265686},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36790722608566284},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.27721935510635376}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.2818.2818","doi":"https://doi.org/10.1182/blood.v126.23.2818.2818","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2818.2818","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2550526788","https://openalex.org/W3031665482","https://openalex.org/W2565189247","https://openalex.org/W4408909345","https://openalex.org/W2617327097","https://openalex.org/W2564965553","https://openalex.org/W4310093707","https://openalex.org/W2586987584","https://openalex.org/W2570736466","https://openalex.org/W4310106661"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Pegylated":[2],"interferon":[3],"alpha-2a":[4],"(Peg":[5],"INF2a)":[6],"has":[7],"been":[8],"demonstrated":[9],"to":[10,57,440,444],"be":[11,441],"active":[12,678],"therapy":[13,34,58,245,700],"for":[14,51,67,185,191,198,209,246],"high-risk":[15],"essential":[16],"thrombocythemia":[17],"(ET),":[18],"polycythemia":[19],"vera":[20],"(PV),":[21],"and":[22,53,69,111,144,181,197,203,227,314,329,344,365,380,457,522,553,679],"early":[23],"myelofibrosis":[24],"(MF).":[25],"We":[26],"retrospectively":[27],"analyzed":[28,50],"the":[29,41,74,113,210,291,465,483,685,692],"outcomes":[30],"of":[31,43,235,253,282,446,684,687,694,706,708],"Peg":[32,254,292,561,675,709],"INF2a":[33,255,293,562,676,710],"in":[35,93,170,215,220,224,229,304,310,317,325,332,340,347,361,368,376,383,391,414,422,431,453,460,508,513,518,524,711],"myeloproliferative":[36],"(MPN)":[37],"patients":[38,130,138,142,147,151,172,236,306,312,327,342,363,370,378,385,393,401,416,424,433,455,467,475,488,498,510,515,520,538,544,549,555,695],"treated":[39],"outside":[40,683],"constraints":[42],"a":[44,418,427,504,535,541,688],"clinical":[45,54,119,689],"trial.":[46,690],"Methods:":[47],"Charts":[48],"were":[49,71,95,131,135,152,402,438,499],"demographic":[52],"data.":[55],"Toxicity":[56],"was":[59,160,168,187,193,200,256,265,274,284,294,412,506],"assessed":[60],"per":[61,472],"CTCAE":[62],"3.0":[63],"criteria.":[64],"Therapeutic":[65],"responses":[66],"ET":[68,141,192,485],"PV":[70,137,186],"calculated":[72,96],"by":[73,97,404,501],"revised":[75,114],"ELN/IWG-MRT":[76,405],"criteria":[77,406],"including":[78],"complete":[79,99,409],"remission":[80,410,420],"(CR),":[81,101],"partial":[82,419],"resmission":[83],"(PR),":[84],"no":[85,451],"response":[86,100,103,106,109,452,568,580],"(NR),":[87],"or":[88,125,429],"progressive":[89,458],"disease":[90,123,459],"(PD).":[91],"Responses":[92,564],"MF":[94,146,150,199,212],"EUNMET:":[98,650],"major":[102],"(MR),":[104],"moderate":[105],"(MoR),":[107],"minor":[108],"(MiR)":[110],"NRand":[112],"IWG-MRT/ELN":[115],"criteria:":[116,503,569,581],"CR,":[117,536],"PR,":[118],"improvement":[120],"(CI),":[121],"stable":[122],"(SD)":[124],"PD.":[126],"Results:":[127],"Patients:":[128],"75":[129],"identified":[132],"overall.":[133],"There":[134],"36":[136],"(48%),":[139],"20":[140,484],"(26.7%),":[143],"19":[145,211,497],"(25.6%).":[148],"Thirteen":[149],"post-PV/ET":[153],"MF.":[154],"The":[155,233,261,270,279,351],"median":[156,262,271,280],"age":[157],"at":[158,240,301,322,337,358,373,388,469],"diagnosis":[159],"51.5":[161],"yrs":[162],"(range":[163,259,268,277,287],"28.8-75.1).":[164],"JAK2":[165],"V617":[166],"mutation":[167],"present":[169],"53":[171],"(70.7%).":[173],"Median":[174,250],"baseline":[175],"hemoglobin":[176],"(g/dL),":[177],"leukocyte":[178],"(x10":[179],"9),":[180],"platelet":[182,491],"count":[183],"(x109)":[184],"13.6,":[188],"8.6,":[189],"369,":[190],"12.5,":[194],"6.8,":[195],"517,":[196],"11.4,":[201],"8.0,":[202],"420,":[204],"respectively.":[205],"DIPSS":[206],"risk":[207],"category":[208],"patients:":[213],"Low":[214],"6":[216,377,624],"(31.5%)":[217],"patients,":[218,486],"Intermediate-1":[219],"3":[221,316,384,543,591,660],"(15.7%),":[222],"Intermediate-2":[223],"8":[225,415],"(42%),":[226],"High":[228],"2":[230,309,331,346,367,382,509,635],"(10.5%)":[231,637],"patients.":[232],"majority":[234,693],"(82.2%)":[237],"had":[238,490,696],"received":[239],"least":[241],"one":[242],"prior":[243,704],"cytoreductive":[244,699],"their":[247],"disease.":[248],"Therapy:":[249],"starting":[251],"dose":[252,264,273],"45":[257],"micrograms/week":[258,267,276],"45-90).":[260],"peak":[263],"90":[266],"45-270).":[269],"tolerated":[272],"60":[275],"5.6-180).":[278],"duration":[281],"treatment":[283],"24":[285],"months":[286],"3.6-85).":[288],"Toxicity:":[289],"Overall":[290],"well":[295],"tolerated.":[296],"Hematological":[297],"toxicity":[298,355],"included:":[299,356],"leukopenia":[300],"grade":[302,308,315,323,330,338,345,359,366,374,381,389],"1":[303,318,324,333,339,348,360,375,390,461,525,531,628,647,652],"13":[305,341],"(17.3%),":[307],"5":[311,537,548,554,603,612,656,664,668],"(6.7%),":[313],"patient":[319,334,349,462,526,532],"(1.3%),":[320,335],"anemia":[321],"10":[326,474],"(13.3%)":[328],"thrombocytopenia":[336],"(17.3%)":[343],"(1.3%).":[350],"most":[352],"common":[353],"non-hematologic":[354],"fatigue":[357],"14":[362,595,599],"(18.7%)":[364],"4":[369,392,514,616,620,639],"(5.3%),":[371],"transaminitis":[372],"(8%)":[379],"(4%),":[386],"myalgias":[387],"(5.3%).":[394,527],"Response:":[395],"See":[396],"Table":[397,559],"#1":[398],"PV/ET:":[399],"56":[400],"evaluated":[403,500],"overall:":[407],"A":[408],"(CR)":[411],"seen":[413,507],"(14.3%),":[417],"(PR)":[421],"18":[423,432],"(32.1%),":[425],"either":[426],"CR":[428],"PR":[430,505],"(32.1%)":[434],"when":[435,681],"histologic":[436],"remissions":[437],"unable":[439],"documented":[442],"due":[443],"lack":[445],"restaging":[447],"bone":[448],"marrow":[449],"examination,":[450],"11":[454],"(19.6%),":[456],"(1.8%).":[463],"Of":[464,482],"12":[466,487,519,643],"receiving":[468],"least1":[470],"phlebotomy":[471,478],"month,":[473],"(83.3%)":[476],"became":[477],"independent":[479],"with":[480,534,540,546,551,557],"therapy.":[481],"(60%)":[489],"normalization":[492],"(<400":[493],"x":[494],"109).":[495],"MF:":[496,631],"IWG-ELN":[502,567],"(10.5%),":[511],"CI":[512],"(21.1%),":[516],"SD":[517],"(63.2%),":[521],"PD":[523],"Utilizing":[528],"EUNMET":[529],"critieria:":[530],"(5.3%)":[533,649,654],"(26.3%)":[539,550,556,658,666,670],"MR,":[542],"(15.8%)":[545,662],"MoR,":[547],"MiR,":[552],"NR.":[558],"1.":[560],"Patient":[563],"RESPONSE":[565],"Disease":[566],"(Patient":[570,582],"#,":[571,583],"%)":[572,584],"(Barosi,":[573,585],"Blood":[574,577,586],"2013,":[575],"Tefferi,":[576],"2013)":[578],"EUMET":[579],"2005)":[587],"PV:":[588],"N=36":[589],"CR:":[590,611,651],"pts":[592,596,600,604,613,617,621,625,636,640,644,657,661,665,669],"(8.3%)":[593],"PR:":[594,615,634],"(38.8%)":[597,601],"CR/PR:":[598,619],"NR:":[602,623,667],"(13.8%)":[605],"PD:":[606,627,646],"0":[607],"NA":[608,630],"ET:":[609],"N=20":[610],"(25%)":[614],"(20%)":[618,622],"(30%)":[626],"(5%)":[629],"N=19":[632],"IWG-ELN:":[633],"CI:":[638],"(21.1%)":[641],"SD:":[642],"(63.2%)":[645],"pt":[648,653],"MR:":[655],"MoR:":[659],"MiR:":[663],"NA:":[671],"Not":[672],"applicable":[673],"Conclusions:":[674],"is":[677],"well-tolerated":[680],"administered":[682],"support":[686],"Given":[691],"previously":[697],"failed":[698],"these":[701],"results":[702],"substantiate":[703],"reports":[705],"efficacy":[707],"MPNs.":[712],"Disclosures":[713],"Mesa:":[714],"Pfizer:":[715],"Research":[716,719,722,730,734,738,741],"Funding;":[717,720,723,731,735,739],"Gilead:":[718],"Promedior:":[721],"Novartis":[724],"Pharmaceuticals":[725],"Corporation:":[726,733],"Consultancy;":[727],"CTI":[728],"Biopharma:":[729],"Incyte":[732],"NS":[736],"Pharma:":[737],"Genentech:":[740],"Funding.":[742]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-12-08T00:00:00"}